-
Meningococcal ACWY
-
Meningococcal B
Current
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
MMWR April 18, 2024 / 73(15);345–350
-
Meningococcal ACWY
-
Meningococcal B
Current
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices
MMWR, September 25, 2020, Volume 69(9); 1–41
Archived
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons – Advisory Committee on Immunization Practices (ACIP), 2016
MMWR, November 4, 2016, Vol. 65(43);1189–1194
Archived
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
MMWR, June 20, 2014; 63(24):527-530
Archived
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, March 22, 2013; 62(RR02):1-22
Archived
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
MMWR, January 25, 2013; 62(3):52-4
Archived
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
MMWR, October 14, 2011; 60(40):1391-2
Archived
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, August 5, 2011; 60(30):1018-1019
Archived
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, January 28, 2011; 60(03):72-76
Archived
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, March 12, 2010; 59(09):273
Archived
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
MMWR, September 25, 2009; 58(37):1042-1043
Archived
Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
MMWR, December 7, 2007; 56(48):1265-1266
Archived
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
MMWR, August 10, 2007; 56(31):794-795
Archived
Prevention and Control of Meningococcal Disease
MMWR, May 27, 2005, Vol. 54(RR07):1-21
Archived
Prevention and Control of Meningococcal Disease
MMWR June 30, 2000 / Vol. 49 / No. RR-07
Archived
Meningococcal Disease and College Students
MMWR June 30, 2000 / Vol. 49 / No. RR-07
